Analysts Estimates and Ratings National Beverage Corp.(NASDAQ:FIZZ): Pfizer, Inc.(NYSE:PFE)

0
4

National Beverage Corp. (FIZZ) will report its next earnings on Mar 05. The company reported the earnings of $0.57/Share in the last quarter where the estimated EPS by analysts was $0.5/share. The difference between the expected and actual EPS was $0.07/share, which represents an Earnings surprise of 14%.

Many analysts are providing their Estimated Earnings analysis for National Beverage Corp. and for the current quarter 3 analysts have projected that the stock could give an Average Earnings estimate of $0.54/share. These analysts have also projected a Low Estimate of $0.5/share and a High Estimate of $0.58/share.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for National Beverage Corp. as 235.8 Million. According to these analysts, the Low Revenue Estimate for National Beverage Corp. is 230 Million and the High Revenue Estimate is 244.71 Million. The company had Year Ago Sales of 239.91 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for FIZZ to be -7.1%. They are projecting Next Quarter growth of -2.7%. For the next 5 years, National Beverage Corp. is expecting Growth of -7.89% per annum, whereas in the past 5 years the growth was -17.67% per annum.

Some buy side analysts are also providing their Analysis on National Beverage Corp., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.83 and Average Volume (3 months) is 339.79 million. The company’s P/E (price to earnings) ratio is 15.87 and Forward P/E ratio of 16.99.

The company shows its Return on Assets (ROA) value of 22.2%. The Return on Equity (ROE) value stands at 31.2%. While it’s Return on Investment (ROI) value is 41.8%.

While looking at the Stock’s Performance, National Beverage Corp. currently shows a Weekly Performance of 1.96%, where Monthly Performance is -7.94%, Quarterly performance is -22.6%, 6 Months performance is -8.68% and yearly performance percentage is -29.31%. Year to Date performance value (YTD perf) value is -20.44%. The Stock currently has a Weekly Volatility of 11.25% and Monthly Volatility of 10.45%.

Pfizer, Inc. (PFE) will report its next earnings on Apr 28 BMO. The company reported the earnings of $0.55/Share in the last quarter where the estimated EPS by analysts was $0.57/share. The difference between the expected and actual EPS was $-0.02/share, which represents an Earnings surprise of -3.5%.

Many analysts are providing their Estimated Earnings analysis for Pfizer, Inc. and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $0.73/share. These analysts have also projected a Low Estimate of $0.67/share and a High Estimate of $0.76/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Pfizer, Inc. as 11.93 Billion. According to these analysts, the Low Revenue Estimate for Pfizer, Inc. is 11.84 Billion and the High Revenue Estimate is 12.01 Billion. The company had Year Ago Sales of 12.99 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for PFE to be -17.7%. They are projecting Next Quarter growth of -13.75%. For the next 5 years, Pfizer, Inc. is expecting Growth of -2.77% per annum, whereas in the past 5 years the growth was -5.08% per annum.

Some buy side analysts are also providing their Analysis on Pfizer, Inc., where 4 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.38 and Average Volume (3 months) is 30.48 million. The company’s P/E (price to earnings) ratio is 10.58 and Forward P/E ratio of 9.56.

The company shows its Return on Assets (ROA) value of 10%. The Return on Equity (ROE) value stands at 26.4%. While it’s Return on Investment (ROI) value is 14.7%.

While looking at the Stock’s Performance, Pfizer, Inc. currently shows a Weekly Performance of -7.65%, where Monthly Performance is -14.34%, Quarterly performance is -24.29%, 6 Months performance is -18.05% and yearly performance percentage is -29.1%. Year to Date performance value (YTD perf) value is -24.2%. The Stock currently has a Weekly Volatility of 6.24% and Monthly Volatility of 5.48%.

SHARE